Monoclonal antibodies binding data for SARS-CoV-2 proteins.

Mishra N, Teyra J, Boytz R, Miersch S, Merritt TN, Cardarelli L, Gorelik M, Mihalic F, Jemth P, Davey RA, Sidhu SS, Leung DW, Amarasinghe GK

Data Brief 43 (-) 108415 [2022-08-00; online 2022-06-24]

SARS-CoV-2 pandemic opens up the curiosity of understanding the coronavirus. This demand for the development of the regent, which can be used for academic and therapeutic applications. The present data provide the biochemical characterization of synthetically developed monoclonal antibodies for the SARS-CoV-2 proteins. The antibodies from phage-displayed antibody libraries were selected with the SARS-CoV-2 proteins immobilized in microwell plates. The clones which bind to the antigen in Fab-phage ELISA were selected, and a two-point competitive phage ELISA was performed. Antibodies binding kinetic of IgGs for SARS-CoV2 proteins further carried with B.L.I. Systematic analysis of binding with different control proteins and purified SARS-CoV-2 ensured the robustness of the antibodies.

Category: Biochemistry

Category: Health

Type: Journal article

PubMed 35789908

DOI 10.1016/j.dib.2022.108415

Crossref 10.1016/j.dib.2022.108415

pmc: PMC9232259
pii: S2352-3409(22)00612-6

Publications 9.5.0